Cargando…
Biliary Atresia in 2021: Epidemiology, Screening and Public Policy
Biliary atresia (BA) is a rare newborn liver disease with significant morbidity and mortality, especially if not recognized and treated early in life. It is the most common cause of liver-related death in children and the leading indication for liver transplantation in the pediatric population. Time...
Autores principales: | Schreiber, Richard A., Harpavat, Sanjiv, Hulscher, Jan B. F., Wildhaber, Barbara E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876662/ https://www.ncbi.nlm.nih.gov/pubmed/35207269 http://dx.doi.org/10.3390/jcm11040999 |
Ejemplares similares
-
Biliary Atresia: 50 Years after the First Kasai
por: Wildhaber, Barbara E.
Publicado: (2012) -
Newborn biliary atresia screening with the stool colour card: a questionnaire survey of parents
por: Borgeat, Morgane, et al.
Publicado: (2018) -
A phase 2 trial of N-Acetylcysteine in Biliary atresia after Kasai portoenterostomy
por: Tessier, Mary Elizabeth M., et al.
Publicado: (2019) -
Variability of Care and Access to Transplantation for Children with Biliary Atresia Who Need a Liver Replacement
por: de Ville de Goyet, Jean, et al.
Publicado: (2022) -
Cholangitis Definition and Treatment after Kasai Hepatoportoenterostomy for Biliary Atresia: A Delphi Process and International Expert Panel
por: Calinescu, Ana M., et al.
Publicado: (2022)